ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

DCT Survey Shatters Myth That Young Investigator Have Difficulty Getting Grants – They’re Doing Better Than Those Over Age 40

August 3, 1984

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

Radiosensitizer Screen Concept OK’d, Acoustic Microscopy Delayed

March 2, 1990

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977

P01 Reviewers Asked To Look Closely At Number Of Projects

October 2, 1992

NCI Cooperative Group Clinical Trials Listed

April 24, 2009